These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12649576)

  • 1. 11beta-hydroxysteroid dehydrogenase type 1 deficiency ('apparent cortisone reductase deficiency') in a 6-year-old boy.
    Małunowicz EM; Romer TE; Urban M; Bossowski A
    Horm Res; 2003; 59(4):205-10. PubMed ID: 12649576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent cortisone reductase deficiency: a functional defect in 11beta-hydroxysteroid dehydrogenase type 1.
    Jamieson A; Wallace AM; Andrew R; Nunez BS; Walker BR; Fraser R; White PC; Connell JM
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3570-4. PubMed ID: 10522997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A follow-up history of young man with apparent cortisone reductase deficiency (ACRD) - several years after diagnosis.
    Zajkowska A; Rydzewska M; Wojtkielewicz K; Pomaski J; Romer T; Bossowski A
    Pediatr Endocrinol Diabetes Metab; 2017; 23(1):42-48. PubMed ID: 29073307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple LC-MS/MS method for the determination of cortisol, cortisone and tetrahydro-metabolites in human urine: assay development, validation and application in depression patients.
    Zhai X; Chen F; Zhu C; Lu Y
    J Pharm Biomed Anal; 2015 Mar; 107():450-5. PubMed ID: 25668797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism.
    Monder C; Shackleton CH; Bradlow HL; New MI; Stoner E; Iohan F; Lakshmi V
    J Clin Endocrinol Metab; 1986 Sep; 63(3):550-7. PubMed ID: 3460996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
    Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
    J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital deficiency of 11beta-hydroxysteroid dehydrogenase (apparent mineralocorticoid excess syndrome): diagnostic value of urinary free cortisol and cortisone.
    Palermo M; Delitala G; Mantero F; Stewart PM; Shackleton CH
    J Endocrinol Invest; 2001 Jan; 24(1):17-23. PubMed ID: 11227727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.
    Moore JS; Monson JP; Kaltsas G; Putignano P; Wood PJ; Sheppard MC; Besser GM; Taylor NF; Stewart PM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4172-7. PubMed ID: 10566668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients.
    Kerstens MN; Riemens SC; Sluiter WJ; Pratt JJ; Wolthers BG; Dullaart RP
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):403-11. PubMed ID: 10762282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis.
    N'Gankam V; Uehlinger D; Dick B; Frey BM; Frey FJ
    Kidney Int; 2002 May; 61(5):1859-66. PubMed ID: 11967038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent cortisone reductase deficiency: a rare cause of hyperandrogenemia and hypercortisolism.
    Biason-Lauber A; Suter SL; Shackleton CH; Zachmann M
    Horm Res; 2000; 53(5):260-6. PubMed ID: 11150889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible defect in the inter-conversion between cortisone and cortisol in prepubertal patients with congenital adrenal hyperplasia receiving cortisone acetate therapy.
    Whorwood CB; Warne GL
    J Steroid Biochem Mol Biol; 1991 Oct; 39(4A):461-70. PubMed ID: 1911435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent cortisone reductase deficiency: a unique form of hypercortisolism.
    Phillipov G; Palermo M; Shackleton CH
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3855-60. PubMed ID: 8923828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
    Wiegand S; Richardt A; Remer T; Wudy SA; Tomlinson JW; Hughes B; Grüters A; Stewart PM; Strasburger CJ; Quinkler M
    Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
    Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency.
    Lavery GG; Walker EA; Tiganescu A; Ride JP; Shackleton CH; Tomlinson JW; Connell JM; Ray DW; Biason-Lauber A; Malunowicz EM; Arlt W; Stewart PM
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3827-32. PubMed ID: 18628520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
    Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
    Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.